INS and bacterial infectious disease: An anti-infection and blood glucose management plan was established: nebulization with amphotericin B continued for the treatment of pulmonary mucormycosis, oral Cefdinir and oral Linezolid were used for bacterial infection treatment, and insulin dosage was adjusted.